Clinical Research Directory
Browse clinical research sites, groups, and studies.
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Sponsor: Alnylam Pharmaceuticals
Summary
The purpose of this study is to: * Describe epidemiological and clinical characteristics, natural history and real-world clinical management of ATTR amyloidosis patients * Characterize the safety and effectiveness of patisiran and vutrisiran as part of routine clinical practice in the real-world clinical setting * Describe disease emergence/progression in pre-symptomatic carriers of a known disease-causing transthyretin (TTR) variant
Official title: ConTTRibute: A Global Observational Multicenter Long-Term Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1500
Start Date
2020-11-23
Completion Date
2030-09-01
Last Updated
2026-03-31
Healthy Volunteers
No
Locations (40)
Clinical Trial Site
La Jolla, California, United States
Clinical Trial Site
Los Angeles, California, United States
Clinical Trial Site
Jacksonville, Florida, United States
Clinical Trial Site
Iowa City, Iowa, United States
Clinical Trial Site
Kansas City, Kansas, United States
Clinical Trial Site
Baltimore, Maryland, United States
Clinical Trial Site
Boston, Massachusetts, United States
Clinical Trial Site
New York, New York, United States
Clinical Trial Site
Durham, North Carolina, United States
Clinical Trial Site
Columbus, Ohio, United States
Clinical Trial Site
Philadelphia, Pennsylvania, United States
Clinical Trial Site
Austin, Texas, United States
Clinical Trial Site
Houston, Texas, United States
Clinical Trial Site
Salvador, Brazil
Clinical Trial Site
São Paulo, Brazil
Clinical Trial Site
Sofia, Bulgaria
Clinical Trial Site
Aarhus, Denmark
Clinical Trial Site
Copenhagen, Denmark
Clinical Trial Site
Bordeaux, France
Clinical Trial Site
Bron, France
Clinical Trial Site
Créteil, France
Clinical Trial Site
Le Kremlin-Bicêtre, France
Clinical Trial Site
Marseille, France
Clinical Trial Site
Berlin, Germany
Clinical Trial Site
Giessen, Germany
Clinical Trial Site
Hanover, Germany
Clinical Trial Site
Jerusalem, Israel
Clinical Trial Site
Ramat Gan, Israel
Clinical Trial Site
Milan, Italy
Clinical Trial Site
Naples, Italy
Clinical Trial Site
Palermo, Italy
Clinical Trial Site
Roma, Italy
Clinical Trial Site
Groningen, Netherlands
Clinical Trial Site
Lisbon, Portugal
Clinical Trial Site
Porto, Portugal
Clinical Trial Site
Barcelona, Spain
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Palma, Spain
Clinical Trial Site
New Taipei City, Taiwan
Clinical Trial Site
Taipei, Taiwan